Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Krieg

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Ernst Schering Research Foundation Workshop|August 16, 2000
CpG oligonucleotides as immune adjuvantsA M Krieg
Trends in Microbiology|June 8, 2001
Now I know my CpGsA M Krieg
Arthritis Research|November 30, 2000
A possible cause of joint destruction in septic arthritisA M Krieg
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Minding the Cs and GsA M Krieg
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
The CpG motif: implications for clinical immunologyA M Krieg
Current Opinion in Immunology|February 19, 2000
The role of CpG motifs in innate immunityA M Krieg
Antisense & Nucleic Acid Drug Development|July 12, 2001
From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNAA M Krieg
Oncogene|January 8, 2008
Toll-like receptor 9 (TLR9) agonists in the treatment of cancerA M Krieg
The Journal of Laboratory and Clinical Medicine|August 1, 1996
An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNAA M Krieg
Trends in Microbiology|February 1, 1996
Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNAA M Krieg
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Ernst Schering Research Foundation Workshop|August 16, 2000
CpG oligonucleotides as immune adjuvantsA M Krieg
Trends in Microbiology|June 8, 2001
Now I know my CpGsA M Krieg
Arthritis Research|November 30, 2000
A possible cause of joint destruction in septic arthritisA M Krieg
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Minding the Cs and GsA M Krieg
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
The CpG motif: implications for clinical immunologyA M Krieg
Current Opinion in Immunology|February 19, 2000
The role of CpG motifs in innate immunityA M Krieg
Antisense & Nucleic Acid Drug Development|July 12, 2001
From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNAA M Krieg
Oncogene|January 8, 2008
Toll-like receptor 9 (TLR9) agonists in the treatment of cancerA M Krieg
The Journal of Laboratory and Clinical Medicine|August 1, 1996
An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNAA M Krieg
Trends in Microbiology|February 1, 1996
Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNAA M Krieg
Pageof 14